Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
PCRX > SEC Filings for PCRX > Form 8-K on 12-Mar-2013All Recent SEC Filings

Show all filings for PACIRA PHARMACEUTICALS, INC. | Request a Trial to NEW EDGAR Online Pro



Unregistered Sale of Equity Securities

Item 3.02. Unregistered Sales of Equity Securities.

On March 7, 2013, Pacira Pharmaceuticals, Inc., a Delaware corporation (the "Company"), issued an aggregate of 53,741 shares of common stock of the Company upon warrant exercises by venture funds affiliated with Sanderling Ventures. The warrants, which were issued by the Company in 2009 and 2010 in connection with private placements of convertible promissory notes, were converted pursuant to the cashless exercise provisions set forth in the warrants. Accordingly, the Company received no proceeds from the issuance of the shares issued upon exercise of the warrants. In all cases, the shares were issued to an "accredited investor" (as defined in Rule 501 of Regulation D) without registration under the Securities Act of 1933, as amended (the "Securities Act"), or the securities laws of certain states, in reliance on the exemptions provided by Section 4(2) of the Securities Act, and in reliance on similar exemptions under applicable state laws.

More complete descriptions of the warrants exercised and the purchasers of the shares issued upon exercise of the warrants are provided in a Statement of Changes in Beneficial Ownership on Form 4, filed by the holders of the warrants on March 11, 2013.

  Add PCRX to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for PCRX - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.